您的购物车当前为空
别名 GNE5729
GNE-5729是一种NMDAR 的正向别构调节剂,具有可透过血脑屏障和可口服的优点,对GluN2A,GluN2C和GluN2D的EC50值分别为37 nM,4.7 μM 和9.5 μM,可用于研究神经和精神疾病。

GNE-5729是一种NMDAR 的正向别构调节剂,具有可透过血脑屏障和可口服的优点,对GluN2A,GluN2C和GluN2D的EC50值分别为37 nM,4.7 μM 和9.5 μM,可用于研究神经和精神疾病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,580 | In Stock | |
| 5 mg | ¥ 5,910 | In Stock | |
| 10 mg | ¥ 8,130 | In Stock | |
| 25 mg | ¥ 11,800 | In Stock | |
| 50 mg | ¥ 16,200 | In Stock |
GNE-5729 相关产品
| 产品描述 | GNE-5729 is a positive allosteric modulator of NMDAR with the advantage of crossing the blood-brain barrier and being orally available, with EC50 values of 37 nM, 4.7 μM and 9.5 μM for GluN2A, GluN2C and GluN2D, respectively, and can be used for the study of neurological and psychiatric disorders. |
| 靶点活性 | GluN2A:37 nM (EC50), GluN2C:4.7 μM (EC50), GluN2D:9.5 μM (EC50) |
| 体外活性 | GNE-5729 是一种可透过血脑屏障的 NMDA 受体正变构调节剂,能选择性增强 GluN2A 亚型的活性(EC₅₀ = 37 nM),而对 GluN2C 和 GluN2D 的激活效应较弱(EC₅₀ 分别为 4.7 μM 和 9.5 μM)[1]。 |
| 别名 | GNE5729 |
| 分子量 | 428.2 |
| 分子式 | C17H10Cl2F3N5O |
| CAS No. | 2026635-66-3 |
| Smiles | ClC1=C(N2C(=NC(CN3N=C(C(F)(F)F)C=C3Cl)=CC2=O)C=C1)[C@H]4[C@H](C#N)C4 |
| 密度 | 1.71 g/cm3 (Predicted) |
| 颜色 | Yellow |
| 物理性状 | Solid |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 80 mg/mL (186.83 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (7.71 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容